Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion.
Loftus PG, Watson L, Deedigan LM, Camarillo-Retamosa E, Dwyer RM, O'Flynn L, Alagesan S, Griffin M, O'Brien T, Kerin MJ, et al. Int J Cancer. 2021 Mar 1; 148(5):1245-1259. Epub 2020 Dec 2.